ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ONVO Organovo Holdings Inc

0.94
0.0089 (0.96%)
Pre Mercado
Última actualización: 07:48:33
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Organovo Holdings Inc ONVO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0089 0.96% 0.94 07:48:33
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.9311
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/4/202407:05GLOBEOrganovo Announces Positive Phase 2 Results for FXR314 in..
08/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
08/2/202415:56EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202407:05EDGAR2Form 8-K - Current report
26/1/202416:09EDGAR2Form S-3 - Registration statement under Securities Act of..
25/1/202407:05GLOBEOrganovo Presents FXR314 3D Human Tissue Model Findings That..
09/1/202407:05GLOBEOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming..
28/12/202315:05EDGAR2Form 8-K - Current report
22/12/202305:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202307:05GLOBEOrganovo Provides Timing for Release of FXR314 Phase 2 NASH..
01/12/202315:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/11/202317:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202317:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202317:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:41EDGAR2Form 144 - Report of proposed sale of securities
13/11/202307:05GLOBECORRECTION – Organovo Highlights FXR314 Combination Therapy..
09/11/202316:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202307:05GLOBEOrganovo Highlights FXR314 Combination Therapy Potential and..
03/11/202307:05EDGAR2Form 8-K - Current report
22/9/202315:05EDGAR2Form 8-K/A - Current report: [Amend]
13/9/202316:06EDGAR2Form DEF 14A - Other definitive proxy statements
13/9/202316:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202315:11EDGAR2Form 8-K - Current report
08/9/202311:46GLOBEOrganovo to Participate in the H.C. Wainwright Global..
05/9/202305:04EDGAR2Form 8-K - Current report
23/8/202307:05GLOBEOrganovo Advances Clinical Timelines for FXR314 and Provides..
22/8/202315:45EDGAR2Form 8-K - Current report
10/8/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202315:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/7/202315:27EDGAR2Form 8-K - Current report
14/7/202316:05EDGAR2Form PRE 14A - Other preliminary proxy statements
29/6/202315:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..

Su Consulta Reciente

Delayed Upgrade Clock